Abstract
Neurodegenerative diseases such as Alzheimer’s, Parkinson’s and Huntington disease have serious concern due to its effect on the quality of life of affected persons. They have some limitations at diagnostic as well as the treatment level. Introducing nanotechnology, for the treatment of these diseases may contribute significantly to solve the problem. There are several treatment strategies for the neurodegenerative diseases, but most of them fail to cross the Blood-Brain Barrier (BBB). The present review highlights the application of nanotechnology during last the 20 years for the treatment of neurodegenerative diseases.
Keywords: Nanotechnology, nanoparticles, neurodegenerative disease, Alzheimer's disease, Parkinson's disease, Huntington's disease.
Graphical Abstract
CNS & Neurological Disorders - Drug Targets
Title:Nanotechnology: Its Application in Treating Neurodegenerative Diseases
Volume: 20 Issue: 1
Author(s): Falaq Naz and Yasir Hasan Siddique*
Affiliation:
- Department of Zoology, Drosophila Transgenic Laboratory, Section of Genetics, Faculty of Life Sciences, Aligarh Muslim University, Aligarh-202002, Uttar Pradesh,India
Keywords: Nanotechnology, nanoparticles, neurodegenerative disease, Alzheimer's disease, Parkinson's disease, Huntington's disease.
Abstract: Neurodegenerative diseases such as Alzheimer’s, Parkinson’s and Huntington disease have serious concern due to its effect on the quality of life of affected persons. They have some limitations at diagnostic as well as the treatment level. Introducing nanotechnology, for the treatment of these diseases may contribute significantly to solve the problem. There are several treatment strategies for the neurodegenerative diseases, but most of them fail to cross the Blood-Brain Barrier (BBB). The present review highlights the application of nanotechnology during last the 20 years for the treatment of neurodegenerative diseases.
Export Options
About this article
Cite this article as:
Naz Falaq and Siddique Hasan Yasir *, Nanotechnology: Its Application in Treating Neurodegenerative Diseases, CNS & Neurological Disorders - Drug Targets 2021; 20 (1) . https://dx.doi.org/10.2174/1871527319666200916121515
DOI https://dx.doi.org/10.2174/1871527319666200916121515 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial (Thematic Issue: Neuroglia as a Central Element of Neurological Diseases: An Underappreciated Target for Therapeutic Intervention)
Current Neuropharmacology Severe Mental Disorders from a Cognitive-Behavioural Perspective: A Comprehensive Review from Conceptualization to Intervention
Current Psychiatry Reviews Improved Prediction of Protein Ligand-Binding Sites Using Random Forests
Protein & Peptide Letters Unsafe Abortion: The Silent Endemic; An Avoidable Cause of Maternal Mortality. A Review
Current Women`s Health Reviews Target Based Drug Design - A Reality in Virtual Sphere
Current Medicinal Chemistry Maternal Nutrient Restriction is not Equivalent to Maternal Biological Stress
Current Drug Targets Word Forms of Modern Japanese Sound Symbolic Words Not Listed in Dictionaries
Neuroscience and Biomedical Engineering (Discontinued) Extracellular Vesicles as Novel Delivery Tools for Cancer Treatment
Current Cancer Drug Targets Pharmacogenomics
Current Drug Metabolism Obstacles and Opportunities for Cholinergic Drug Development in the Treatment of Cognitive Disorders
Current Pharmaceutical Design Impact of Patient Knowledge of Hypertension Complications on Adherence to Antihypertensive Therapy
Current Hypertension Reviews Protein Kinase C Isozyme Selective Peptides - A Current View of What they Tell Us About Location and Function of Isozymes in the Heart
Current Pharmaceutical Design AβPP-induced UPR Transcriptomic Signature of Glial Cells to Oxidative Stress as an Adaptive Mechanism to Preserve Cell Function and Survival
Current Alzheimer Research From Pharmacotherapy to Pathophysiology: Emerging Mechanisms of Apolipoprotein D in Psychiatric Disorders
Current Molecular Medicine Glycyrrhizic Acid Ameliorates Cognitive Impairment in a Rat Model of Vascular Dementia Associated with Oxidative Damage and Inhibition of Voltage-Gated Sodium Channels
CNS & Neurological Disorders - Drug Targets Nuclear Factor Kappa-light-chain-enhancer of Activated B Cells (NF-κB) – a Friend, a Foe, or a Bystander - in the Neurodegenerative Cascade and Pathogenesis of Alzheimer's Disease
CNS & Neurological Disorders - Drug Targets Neuroimaging of Non-Accidental Injury
Current Pediatric Reviews Reciprocity in Microbiome and Immune System Interactions and its Implications in Disease and Health
Inflammation & Allergy - Drug Targets (Discontinued) The Other Target for Ribosomal Antibiotics: Inhibition of Bacterial Ribosomal Subunit Formation
Infectious Disorders - Drug Targets CXCR7 Participates in CXCL12-mediated Cell Cycle and Proliferation Regulation in Mouse Neural Progenitor Cells
Current Molecular Medicine